TY - JOUR
T1 - Value Creation Through Artificial Intelligence and Cardiovascular Imaging
T2 - A Scientific Statement From the American Heart Association
AU - on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention; and Council on Lifelong Congenital Heart Disease and Heart Health in the Young
AU - Hanneman, Kate
AU - Playford, David
AU - Dey, Damini
AU - van Assen, Marly
AU - Mastrodicasa, Domenico
AU - Cook, Tessa S.
AU - Gichoya, Judy Wawira
AU - Williamson, Eric E.
AU - Rubin, Geoffrey D.
N1 - Publisher Copyright:
© 2024 American Heart Association, Inc.
PY - 2024/2/6
Y1 - 2024/2/6
N2 - Multiple applications for machine learning and artificial intelligence (AI) in cardiovascular imaging are being proposed and developed. However, the processes involved in implementing AI in cardiovascular imaging are highly diverse, varying by imaging modality, patient subtype, features to be extracted and analyzed, and clinical application. This article establishes a framework that defines value from an organizational perspective, followed by value chain analysis to identify the activities in which AI might produce the greatest incremental value creation. The various perspectives that should be considered are highlighted, including clinicians, imagers, hospitals, patients, and payers. Integrating the perspectives of all health care stakeholders is critical for creating value and ensuring the successful deployment of AI tools in a real-world setting. Different AI tools are summarized, along with the unique aspects of AI applications to various cardiac imaging modalities, including cardiac computed tomography, magnetic resonance imaging, and positron emission tomography. AI is applicable and has the potential to add value to cardiovascular imaging at every step along the patient journey, from selecting the more appropriate test to optimizing image acquisition and analysis, interpreting the results for classification and diagnosis, and predicting the risk for major adverse cardiac events.
AB - Multiple applications for machine learning and artificial intelligence (AI) in cardiovascular imaging are being proposed and developed. However, the processes involved in implementing AI in cardiovascular imaging are highly diverse, varying by imaging modality, patient subtype, features to be extracted and analyzed, and clinical application. This article establishes a framework that defines value from an organizational perspective, followed by value chain analysis to identify the activities in which AI might produce the greatest incremental value creation. The various perspectives that should be considered are highlighted, including clinicians, imagers, hospitals, patients, and payers. Integrating the perspectives of all health care stakeholders is critical for creating value and ensuring the successful deployment of AI tools in a real-world setting. Different AI tools are summarized, along with the unique aspects of AI applications to various cardiac imaging modalities, including cardiac computed tomography, magnetic resonance imaging, and positron emission tomography. AI is applicable and has the potential to add value to cardiovascular imaging at every step along the patient journey, from selecting the more appropriate test to optimizing image acquisition and analysis, interpreting the results for classification and diagnosis, and predicting the risk for major adverse cardiac events.
KW - AHA Scientific Statements
KW - artificial intelligence
KW - cardiac imaging techniques
KW - cardiovascular diseases
KW - magnetic resonance imaging
KW - radiology
UR - http://www.scopus.com/inward/record.url?scp=85184294794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85184294794&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000001202
DO - 10.1161/CIR.0000000000001202
M3 - Review article
C2 - 38193315
AN - SCOPUS:85184294794
SN - 0009-7322
VL - 149
SP - E296-E311
JO - Circulation
JF - Circulation
IS - 6
ER -